BUZZ-Myriad Genetics Inc: Cuts revenue, profit forecast for full year
** Molecular diagnostic's shares down 16 pct at $31.78 in extended trading
** Company cuts revenue forecast to $730 mln-$740 mln for year ending June 30 from $800-$820 mln; adjusted profit/shr forecast to $1.50-$1.55 from $1.75-$1.85
** Says cut due to lag in getting reimbursement coverage for diagnostic services and increase in work-in-process
** CEO Peter Meldrum leaves company; To be suceeded by Mark Capone
** Stock gained 62 pct in 2014
© Thomson Reuters 2017 All rights reserved.